LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Bezabih, Yihienew Mequanint"
  2. AU="Hirsinger, Estelle"
  3. AU="Robles-Musso Castillo, Emilio"
  4. AU="Vahdatihassani, Faezeh"
  5. AU="Maria Pala"
  6. AU=Singh Indra
  7. AU="Gallacher, Nicola"
  8. AU="Chen, Pei-Min"
  9. AU=Andre L
  10. AU="Aleksandra I. Pivovarova"
  11. AU="Cruz, Thainá Gabriele Camargo da"
  12. AU="Atkins, Peter"

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Factors associated with first-line antiretroviral treatment failure in adult HIV-positive patients: a case-control study from Ethiopia.

    Bezabih, Yihienew Mequanint / Beyene, Fekadu / Bezabhe, Woldesellassie M

    BMC infectious diseases

    2019  Volume 19, Issue 1, Page(s) 537

    Abstract: Background: Treatment failure has become a significant challenge in patients taking antiretroviral therapy (ART). The aim of the present study was to identify risk factors for first-line ART failure among patients attending clinical follow-up.: ... ...

    Abstract Background: Treatment failure has become a significant challenge in patients taking antiretroviral therapy (ART). The aim of the present study was to identify risk factors for first-line ART failure among patients attending clinical follow-up.
    Methods: A 1:2 matched case-control study (by age, sex, and treatment duration since initiated on ART) was conducted from June 2015 to July 2017 on adult patients (aged ≥15 years) who were on ART for at least 6 months. Cases were selected from patients who were switched to second-line ART after first-line ART failure (viral load ≥1000 copies/mL). Controls were randomly selected from patients on first-line ART with viral load < 50 copies/mL. Data were collected using an interview questionnaire, reviewing chart and electronic health records and laboratory tests. Multivariate logistic regression analysis was performed to identify risk factors for treatment failure.
    Results: Of the 273 patients who participated in this study, 55% were males. Ninety-one cases were compared with 182 controls. The median age of participants was 40 years and the median duration of treatment since initiated on ART was 69 months. Independent risk factors associated with first-line antiretroviral treatment failure were discontinuation of ART (adjusted odds ratio (AOR) = 9.8, 95% confidence interval (CI): 4.0-23.8), baseline CD4 lymphocyte count ≤50 cells/mm
    Conclusions: Our findings underscore the importance of avoiding ART discontinuation of any duration, early initiation of ART and diarrhea management to prevent first-line ART failure.
    MeSH term(s) Adolescent ; Adult ; Anti-Retroviral Agents/adverse effects ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Case-Control Studies ; Diarrhea/etiology ; Diet ; Ethiopia ; Female ; HIV Infections/drug therapy ; Humans ; Male ; Medication Adherence ; Middle Aged ; Odds Ratio ; Risk Factors ; Treatment Failure ; Young Adult
    Chemical Substances Anti-Retroviral Agents
    Language English
    Publishing date 2019-06-18
    Publishing country England
    Document type Journal Article
    ISSN 1471-2334
    ISSN (online) 1471-2334
    DOI 10.1186/s12879-019-4170-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Comparison of renin-angiotensin-aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes: systematic review and meta-analysis

    Bezabih, Yihienew Mequanint / Bezabih, Alemayehu / Alamneh, Endalkachew / Peterson, Gregory M. / Bezabhe, Woldesellassie M.

    medRxiv

    Abstract: Introduction: The effects of renin-angiotensin-aldosterone system (RAAS) inhibitors on the clinical outcomes of coronavirus disease-19 (COVID-19) have been conflicting in different studies. This meta-analysis was undertaken to provide more conclusive ... ...

    Abstract Introduction: The effects of renin-angiotensin-aldosterone system (RAAS) inhibitors on the clinical outcomes of coronavirus disease-19 (COVID-19) have been conflicting in different studies. This meta-analysis was undertaken to provide more conclusive evidence. Methods: A systematic search for published articles was performed in PubMed and EMBASE from January 5 2020 till May 5 2020. Studies that reported the clinical outcomes of patients with COVID-19, stratified by the class of concomitant antihypertensive drug therapy, were included. The Mantel-Haenszel random effects model was used to estimate pooled odds ratio (OR). Results: A total of 6,997 patients with COVID-19 were included, and all of them had hypertension. The overall risk of poor patient outcomes (severe COVID-19 or death) was lower in patients taking RAAS inhibitors (OR=0.84, 95% CI: [0.73, 0.96]; P=0.017) compared with those receiving non-RAAS inhibitor antihypertensives. Patients taking angiotensin-I-converting enzyme inhibitors (ACEIs) were less likely to experience poor clinical outcomes (OR=0.73, 95% CI: [0.58-0.92]; P=0.01) compared with those receiving angiotensin-II receptor blockers (ARBs). In addition, comparison of ACEIs to the rest of non-ACEI antihypertensives gave a consistently decreased risk of poor COVID-19 outcome (OR=0.77, 95% CI: [0.63-0.93]; P=0.002). However, ARBs did not decrease the risk of poor COVID-19 outcomes compared to all other non-ARB antihypertensives (OR=1.13, 95% CI: [0.95-1.35]). Conclusion: The risk of developing severe illness or death from COVID-19 was lower in patients who received RAAS inhibitors compared with those who took non-RAAS inhibitors. ACEIs might be better in decreasing the severity and mortality of COVID-19 than ARBs.
    Keywords covid19
    Language English
    Publishing date 2020-05-25
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2020.05.21.20108993
    Database COVID19

    Kategorien

  3. Article ; Online: Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.

    Kocarnik, Jonathan M / Compton, Kelly / Dean, Frances E / Fu, Weijia / Gaw, Brian L / Harvey, James D / Henrikson, Hannah Jacqueline / Lu, Dan / Pennini, Alyssa / Xu, Rixing / Ababneh, Emad / Abbasi-Kangevari, Mohsen / Abbastabar, Hedayat / Abd-Elsalam, Sherief M / Abdoli, Amir / Abedi, Aidin / Abidi, Hassan / Abolhassani, Hassan / Adedeji, Isaac Akinkunmi /
    Adnani, Qorinah Estiningtyas Sakilah / Advani, Shailesh M / Afzal, Muhammad Sohail / Aghaali, Mohammad / Ahinkorah, Bright Opoku / Ahmad, Sajjad / Ahmad, Tauseef / Ahmadi, Ali / Ahmadi, Sepideh / Ahmed Rashid, Tarik / Ahmed Salih, Yusra / Akalu, Gizachew Taddesse / Aklilu, Addis / Akram, Tayyaba / Akunna, Chisom Joyqueenet / Al Hamad, Hanadi / Alahdab, Fares / Al-Aly, Ziyad / Ali, Saqib / Alimohamadi, Yousef / Alipour, Vahid / Aljunid, Syed Mohamed / Alkhayyat, Motasem / Almasi-Hashiani, Amir / Almasri, Nihad A / Al-Maweri, Sadeq Ali Ali / Almustanyir, Sami / Alonso, Nivaldo / Alvis-Guzman, Nelson / Amu, Hubert / Anbesu, Etsay Woldu / Ancuceanu, Robert / Ansari, Fereshteh / Ansari-Moghaddam, Alireza / Antwi, Maxwell Hubert / Anvari, Davood / Anyasodor, Anayochukwu Edward / Aqeel, Muhammad / Arabloo, Jalal / Arab-Zozani, Morteza / Aremu, Olatunde / Ariffin, Hany / Aripov, Timur / Arshad, Muhammad / Artaman, Al / Arulappan, Judie / Asemi, Zatollah / Asghari Jafarabadi, Mohammad / Ashraf, Tahira / Atorkey, Prince / Aujayeb, Avinash / Ausloos, Marcel / Awedew, Atalel Fentahun / Ayala Quintanilla, Beatriz Paulina / Ayenew, Temesgen / Azab, Mohammed A / Azadnajafabad, Sina / Azari Jafari, Amirhossein / Azarian, Ghasem / Azzam, Ahmed Y / Badiye, Ashish D / Bahadory, Saeed / Baig, Atif Amin / Baker, Jennifer L / Balakrishnan, Senthilkumar / Banach, Maciej / Bärnighausen, Till Winfried / Barone-Adesi, Francesco / Barra, Fabio / Barrow, Amadou / Behzadifar, Masoud / Belgaumi, Uzma Iqbal / Bezabhe, Woldesellassie M Mequanint / Bezabih, Yihienew Mequanint / Bhagat, Devidas S / Bhagavathula, Akshaya Srikanth / Bhardwaj, Nikha / Bhardwaj, Pankaj / Bhaskar, Sonu / Bhattacharyya, Krittika / Bhojaraja, Vijayalakshmi S / Bibi, Sadia / Bijani, Ali / Biondi, Antonio / Bisignano, Catherine / Bjørge, Tone / Bleyer, Archie / Blyuss, Oleg / Bolarinwa, Obasanjo Afolabi / Bolla, Srinivasa Rao / Braithwaite, Dejana / Brar, Amanpreet / Brenner, Hermann / Bustamante-Teixeira, Maria Teresa / Butt, Nadeem Shafique / Butt, Zahid A / Caetano Dos Santos, Florentino Luciano / Cao, Yin / Carreras, Giulia / Catalá-López, Ferrán / Cembranel, Francieli / Cerin, Ester / Cernigliaro, Achille / Chakinala, Raja Chandra / Chattu, Soosanna Kumary / Chattu, Vijay Kumar / Chaturvedi, Pankaj / Chimed-Ochir, Odgerel / Cho, Daniel Youngwhan / Christopher, Devasahayam J / Chu, Dinh-Toi / Chung, Michael T / Conde, Joao / Cortés, Sanda / Cortesi, Paolo Angelo / Costa, Vera Marisa / Cunha, Amanda Ramos / Dadras, Omid / Dagnew, Amare Belachew / Dahlawi, Saad M A / Dai, Xiaochen / Dandona, Lalit / Dandona, Rakhi / Darwesh, Aso Mohammad / das Neves, José / De la Hoz, Fernando Pio / Demis, Asmamaw Bizuneh / Denova-Gutiérrez, Edgar / Dhamnetiya, Deepak / Dhimal, Mandira Lamichhane / Dhimal, Meghnath / Dianatinasab, Mostafa / Diaz, Daniel / Djalalinia, Shirin / Do, Huyen Phuc / Doaei, Saeid / Dorostkar, Fariba / Dos Santos Figueiredo, Francisco Winter / Driscoll, Tim Robert / Ebrahimi, Hedyeh / Eftekharzadeh, Sahar / El Tantawi, Maha / El-Abid, Hassan / Elbarazi, Iffat / Elhabashy, Hala Rashad / Elhadi, Muhammed / El-Jaafary, Shaimaa I / Eshrati, Babak / Eskandarieh, Sharareh / Esmaeilzadeh, Firooz / Etemadi, Arash / Ezzikouri, Sayeh / Faisaluddin, Mohammed / Faraon, Emerito Jose A / Fares, Jawad / Farzadfar, Farshad / Feroze, Abdullah Hamid / Ferrero, Simone / Ferro Desideri, Lorenzo / Filip, Irina / Fischer, Florian / Fisher, James L / Foroutan, Masoud / Fukumoto, Takeshi / Gaal, Peter Andras / Gad, Mohamed M / Gadanya, Muktar A / Gallus, Silvano / Gaspar Fonseca, Mariana / Getachew Obsa, Abera / Ghafourifard, Mansour / Ghashghaee, Ahmad / Ghith, Nermin / Gholamalizadeh, Maryam / Gilani, Syed Amir / Ginindza, Themba G / Gizaw, Abraham Tamirat T / Glasbey, James C / Golechha, Mahaveer / Goleij, Pouya / Gomez, Ricardo Santiago / Gopalani, Sameer Vali / Gorini, Giuseppe / Goudarzi, Houman / Grosso, Giuseppe / Gubari, Mohammed Ibrahim Mohialdeen / Guerra, Maximiliano Ribeiro / Guha, Avirup / Gunasekera, D Sanjeeva / Gupta, Bhawna / Gupta, Veer Bala / Gupta, Vivek Kumar / Gutiérrez, Reyna Alma / Hafezi-Nejad, Nima / Haider, Mohammad Rifat / Haj-Mirzaian, Arvin / Halwani, Rabih / Hamadeh, Randah R / Hameed, Sajid / Hamidi, Samer / Hanif, Asif / Haque, Shafiul / Harlianto, Netanja I / Haro, Josep Maria / Hasaballah, Ahmed I / Hassanipour, Soheil / Hay, Roderick J / Hay, Simon I / Hayat, Khezar / Heidari, Golnaz / Heidari, Mohammad / Herrera-Serna, Brenda Yuliana / Herteliu, Claudiu / Hezam, Kamal / Holla, Ramesh / Hossain, Md Mahbub / Hossain, Mohammad Bellal Hossain / Hosseini, Mohammad-Salar / Hosseini, Mostafa / Hosseinzadeh, Mehdi / Hostiuc, Mihaela / Hostiuc, Sorin / Househ, Mowafa / Hsairi, Mohamed / Huang, Junjie / Hugo, Fernando N / Hussain, Rabia / Hussein, Nawfal R / Hwang, Bing-Fang / Iavicoli, Ivo / Ibitoye, Segun Emmanuel / Ida, Fidelia / Ikuta, Kevin S / Ilesanmi, Olayinka Stephen / Ilic, Irena M / Ilic, Milena D / Irham, Lalu Muhammad / Islam, Jessica Y / Islam, Rakibul M / Islam, Sheikh Mohammed Shariful / Ismail, Nahlah Elkudssiah / Isola, Gaetano / Iwagami, Masao / Jacob, Louis / Jain, Vardhmaan / Jakovljevic, Mihajlo B / Javaheri, Tahereh / Jayaram, Shubha / Jazayeri, Seyed Behzad / Jha, Ravi Prakash / Jonas, Jost B / Joo, Tamas / Joseph, Nitin / Joukar, Farahnaz / Jürisson, Mikk / Kabir, Ali / Kahrizi, Danial / Kalankesh, Leila R / Kalhor, Rohollah / Kaliyadan, Feroze / Kalkonde, Yogeshwar / Kamath, Ashwin / Kameran Al-Salihi, Nawzad / Kandel, Himal / Kapoor, Neeti / Karch, André / Kasa, Ayele Semachew / Katikireddi, Srinivasa Vittal / Kauppila, Joonas H / Kavetskyy, Taras / Kebede, Sewnet Adem / Keshavarz, Pedram / Keykhaei, Mohammad / Khader, Yousef Saleh / Khalilov, Rovshan / Khan, Gulfaraz / Khan, Maseer / Khan, Md Nuruzzaman / Khan, Moien A B / Khang, Young-Ho / Khater, Amir M / Khayamzadeh, Maryam / Kim, Gyu Ri / Kim, Yun Jin / Kisa, Adnan / Kisa, Sezer / Kissimova-Skarbek, Katarzyna / Kopec, Jacek A / Koteeswaran, Rajasekaran / Koul, Parvaiz A / Koulmane Laxminarayana, Sindhura Lakshmi / Koyanagi, Ai / Kucuk Bicer, Burcu / Kugbey, Nuworza / Kumar, G Anil / Kumar, Narinder / Kumar, Nithin / Kurmi, Om P / Kutluk, Tezer / La Vecchia, Carlo / Lami, Faris Hasan / Landires, Iván / Lauriola, Paolo / Lee, Sang-Woong / Lee, Shaun Wen Huey / Lee, Wei-Chen / Lee, Yo Han / Leigh, James / Leong, Elvynna / Li, Jiarui / Li, Ming-Chieh / Liu, Xuefeng / Loureiro, Joana A / Lunevicius, Raimundas / Magdy Abd El Razek, Muhammed / Majeed, Azeem / Makki, Alaa / Male, Shilpa / Malik, Ahmad Azam / Mansournia, Mohammad Ali / Martini, Santi / Masoumi, Seyedeh Zahra / Mathur, Prashant / McKee, Martin / Mehrotra, Ravi / Mendoza, Walter / Menezes, Ritesh G / Mengesha, Endalkachew Worku / Mesregah, Mohamed Kamal / Mestrovic, Tomislav / Miao Jonasson, Junmei / Miazgowski, Bartosz / Miazgowski, Tomasz / Michalek, Irmina Maria / Miller, Ted R / Mirzaei, Hamed / Mirzaei, Hamid Reza / Misra, Sanjeev / Mithra, Prasanna / Moghadaszadeh, Masoud / Mohammad, Karzan Abdulmuhsin / Mohammad, Yousef / Mohammadi, Mokhtar / Mohammadi, Seyyede Momeneh / Mohammadian-Hafshejani, Abdollah / Mohammed, Shafiu / Moka, Nagabhishek / Mokdad, Ali H / Molokhia, Mariam / Monasta, Lorenzo / Moni, Mohammad Ali / Moosavi, Mohammad Amin / Moradi, Yousef / Moraga, Paula / Morgado-da-Costa, Joana / Morrison, Shane Douglas / Mosapour, Abbas / Mubarik, Sumaira / Mwanri, Lillian / Nagarajan, Ahamarshan Jayaraman / Nagaraju, Shankar Prasad / Nagata, Chie / Naimzada, Mukhammad David / Nangia, Vinay / Naqvi, Atta Abbas / Narasimha Swamy, Sreenivas / Ndejjo, Rawlance / Nduaguba, Sabina O / Negoi, Ionut / Negru, Serban Mircea / Neupane Kandel, Sandhya / Nguyen, Cuong Tat / Nguyen, Huong Lan Thi / Niazi, Robina Khan / Nnaji, Chukwudi A / Noor, Nurulamin M / Nuñez-Samudio, Virginia / Nzoputam, Chimezie Igwegbe / Oancea, Bogdan / Ochir, Chimedsuren / Odukoya, Oluwakemi Ololade / Ogbo, Felix Akpojene / Olagunju, Andrew T / Olakunde, Babayemi Oluwaseun / Omar, Emad / Omar Bali, Ahmed / Omonisi, Abidemi E Emmanuel / Ong, Sokking / Onwujekwe, Obinna E / Orru, Hans / Ortega-Altamirano, Doris V / Otstavnov, Nikita / Otstavnov, Stanislav S / Owolabi, Mayowa O / P A, Mahesh / Padubidri, Jagadish Rao / Pakshir, Keyvan / Pana, Adrian / Panagiotakos, Demosthenes / Panda-Jonas, Songhomitra / Pardhan, Shahina / Park, Eun-Cheol / Park, Eun-Kee / Pashazadeh Kan, Fatemeh / Patel, Harsh K / Patel, Jenil R / Pati, Siddhartha / Pattanshetty, Sanjay M / Paudel, Uttam / Pereira, David M / Pereira, Renato B / Perianayagam, Arokiasamy / Pillay, Julian David / Pirouzpanah, Saeed / Pishgar, Farhad / Podder, Indrashis / Postma, Maarten J / Pourjafar, Hadi / Prashant, Akila / Preotescu, Liliana / Rabiee, Mohammad / Rabiee, Navid / Radfar, Amir / Radhakrishnan, Raghu Anekal / Radhakrishnan, Venkatraman / Rafiee, Ata / Rahim, Fakher / Rahimzadeh, Shadi / Rahman, Mosiur / Rahman, Muhammad Aziz / Rahmani, Amir Masoud / Rajai, Nazanin / Rajesh, Aashish / Rakovac, Ivo / Ram, Pradhum / Ramezanzadeh, Kiana / Ranabhat, Kamal / Ranasinghe, Priyanga / Rao, Chythra R / Rao, Sowmya J / Rawassizadeh, Reza / Razeghinia, Mohammad Sadegh / Renzaho, Andre M N / Rezaei, Negar / Rezaei, Nima / Rezapour, Aziz / Roberts, Thomas J / Rodriguez, Jefferson Antonio Buendia / Rohloff, Peter / Romoli, Michele / Ronfani, Luca / Roshandel, Gholamreza / Rwegerera, Godfrey M / S, Manjula / Sabour, Siamak / Saddik, Basema / Saeed, Umar / Sahebkar, Amirhossein / Sahoo, Harihar / Salehi, Sana / Salem, Marwa Rashad / Salimzadeh, Hamideh / Samaei, Mehrnoosh / Samy, Abdallah M / Sanabria, Juan / Sankararaman, Senthilkumar / Santric-Milicevic, Milena M / Sardiwalla, Yaeesh / Sarveazad, Arash / Sathian, Brijesh / Sawhney, Monika / Saylan, Mete / Schneider, Ione Jayce Ceola / Sekerija, Mario / Seylani, Allen / Shafaat, Omid / Shaghaghi, Zahra / Shaikh, Masood Ali / Shamsoddin, Erfan / Shannawaz, Mohammed / Sharma, Rajesh / Sheikh, Aziz / Sheikhbahaei, Sara / Shetty, Adithi / Shetty, Jeevan K / Shetty, Pavanchand H / Shibuya, Kenji / Shirkoohi, Reza / Shivakumar, K M / Shivarov, Velizar / Siabani, Soraya / Siddappa Malleshappa, Sudeep K / Silva, Diego Augusto Santos / Singh, Jasvinder A / Sintayehu, Yitagesu / Skryabin, Valentin Yurievich / Skryabina, Anna Aleksandrovna / Soeberg, Matthew J / Sofi-Mahmudi, Ahmad / Sotoudeh, Houman / Steiropoulos, Paschalis / Straif, Kurt / Subedi, Ranjeeta / Sufiyan, Mu'awiyyah Babale / Sultan, Iyad / Sultana, Saima / Sur, Daniel / Szerencsés, Viktória / Szócska, Miklós / Tabarés-Seisdedos, Rafael / Tabuchi, Takahiro / Tadbiri, Hooman / Taherkhani, Amir / Takahashi, Ken / Talaat, Iman M / Tan, Ker-Kan / Tat, Vivian Y / Tedla, Bemnet Amare A / Tefera, Yonas Getaye / Tehrani-Banihashemi, Arash / Temsah, Mohamad-Hani / Tesfay, Fisaha Haile / Tessema, Gizachew Assefa / Thapar, Rekha / Thavamani, Aravind / Thoguluva Chandrasekar, Viveksandeep / Thomas, Nihal / Tohidinik, Hamid Reza / Touvier, Mathilde / Tovani-Palone, Marcos Roberto / Traini, Eugenio / Tran, Bach Xuan / Tran, Khanh Bao / Tran, Mai Thi Ngoc / Tripathy, Jaya Prasad / Tusa, Biruk Shalmeno / Ullah, Irfan / Ullah, Saif / Umapathi, Krishna Kishore / Unnikrishnan, Bhaskaran / Upadhyay, Era / Vacante, Marco / Vaezi, Maryam / Valadan Tahbaz, Sahel / Velazquez, Diana Zuleika / Veroux, Massimiliano / Violante, Francesco S / Vlassov, Vasily / Vo, Bay / Volovici, Victor / Vu, Giang Thu / Waheed, Yasir / Wamai, Richard G / Ward, Paul / Wen, Yi Feng / Westerman, Ronny / Winkler, Andrea Sylvia / Yadav, Lalit / Yahyazadeh Jabbari, Seyed Hossein / Yang, Lin / Yaya, Sanni / Yazie, Taklo Simeneh Yazie / Yeshaw, Yigizie / Yonemoto, Naohiro / Younis, Mustafa Z / Yousefi, Zabihollah / Yu, Chuanhua / Yuce, Deniz / Yunusa, Ismaeel / Zadnik, Vesna / Zare, Fariba / Zastrozhin, Mikhail Sergeevich / Zastrozhina, Anasthasia / Zhang, Jianrong / Zhong, Chenwen / Zhou, Linghui / Zhu, Cong / Ziapour, Arash / Zimmermann, Ivan R / Fitzmaurice, Christina / Murray, Christopher J L / Force, Lisa M

    JAMA oncology

    2022  Volume 8, Issue 3, Page(s) 420–444

    Abstract: Importance: The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden.: Objective: To ... ...

    Abstract Importance: The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden.
    Objective: To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019.
    Evidence review: The GBD 2019 estimation methods were used to describe cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs) in 2019 and over the past decade. Estimates are also provided by quintiles of the SDI, a composite measure of educational attainment, income per capita, and total fertility rate for those younger than 25 years. Estimates include 95% uncertainty intervals (UIs).
    Findings: In 2019, there were an estimated 23.6 million (95% UI, 22.2-24.9 million) new cancer cases (17.2 million when excluding nonmelanoma skin cancer) and 10.0 million (95% UI, 9.36-10.6 million) cancer deaths globally, with an estimated 250 million (235-264 million) DALYs due to cancer. Since 2010, these represented a 26.3% (95% UI, 20.3%-32.3%) increase in new cases, a 20.9% (95% UI, 14.2%-27.6%) increase in deaths, and a 16.0% (95% UI, 9.3%-22.8%) increase in DALYs. Among 22 groups of diseases and injuries in the GBD 2019 study, cancer was second only to cardiovascular diseases for the number of deaths, years of life lost, and DALYs globally in 2019. Cancer burden differed across SDI quintiles. The proportion of years lived with disability that contributed to DALYs increased with SDI, ranging from 1.4% (1.1%-1.8%) in the low SDI quintile to 5.7% (4.2%-7.1%) in the high SDI quintile. While the high SDI quintile had the highest number of new cases in 2019, the middle SDI quintile had the highest number of cancer deaths and DALYs. From 2010 to 2019, the largest percentage increase in the numbers of cases and deaths occurred in the low and low-middle SDI quintiles.
    Conclusions and relevance: The results of this systematic analysis suggest that the global burden of cancer is substantial and growing, with burden differing by SDI. These results provide comprehensive and comparable estimates that can potentially inform efforts toward equitable cancer control around the world.
    MeSH term(s) Disability-Adjusted Life Years ; Global Burden of Disease ; Global Health ; Humans ; Incidence ; Neoplasms/epidemiology ; Prevalence ; Quality-Adjusted Life Years ; Risk Factors
    Language English
    Publishing date 2022-01-31
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Systematic Review
    ISSN 2374-2445
    ISSN (online) 2374-2445
    DOI 10.1001/jamaoncol.2021.6987
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top